The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Theophylline
Abstract
Theophylline (dimethylxanthine) has been used to treat airway diseases for more than 80 years. It was originally used as a bronchodilator, but the relatively high doses required are associated with frequent side effects, so its use declined as inhaled β2-agonists became more widely used. More recently it has been shown to have antiinflammatory effects in asthma and chronic obstructive pulmonary disease (COPD) at lower concentrations. The molecular mechanism of bronchodilatation is inhibition of phosphodiesterase (PDE)3, but the antiinflammatory effect may be due to inhibition of PDE4 and histone deacetylase-2 activation, resulting in switching off of activated inflammatory genes. Through this mechanism, theophylline also reverses corticosteroid resistance, and this may be of particular value in severe asthma and COPD, wherein histone deacetylase-2 activity is reduced. Theophylline is given systemically (orally as slow-release preparations for chronic treatment and intravenously for acute exacerbations of asthma). Efficacy is related to blood concentrations, which are determined mainly by hepatic metabolism, which may be increased or decreased in several diseases and by concomitant drug therapy. Theophylline is now usually used as an add-on therapy in patients with asthma not well controlled on inhaled corticosteroids with or without long-acting β2-agonists and in patients with COPD with severe disease not controlled by bronchodilator therapy. Side effects are related to plasma concentrations and include nausea, vomiting, and headaches due to PDE inhibition and at higher concentrations to cardiac arrhythmias and seizures due to adenosine A1-receptor antagonism. In the future, low-dose theophylline may be useful in reversing corticosteroid resistance in COPD and severe asthma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
Self-citationGlobal strategy for asthma management and prevention: GINA executive summary
Bateman, E. D., Hurd, S. S., Barnes, P. J., Bousquet, J., Drazen, J. M., FitzGerald, M., Gibson, P., Ohta, K., O'Byrne, P., Pedersen, S. E., et al. (2008) · European Respiratory Journal · doi:10.1183/09031936.00138707 · Cited by 3,203
Self-citationDoes Increased Access to Primary Care Reduce Hospital Readmissions?
Weinberger, M., Oddone, E. Z., & Henderson, W. G. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605303342206 · Cited by 800
Ito, K., Lim, S., Caramori, G., Cosio, B., Chung, K. F., Adcock, I. M., & Barnes, P. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.132556899 · Cited by 512
Self-citationTheophylline Restores Histone Deacetylase Activity and Steroid Responses in COPD Macrophages
Cosio, B. G., Tsaprouni, L., Ito, K., Jazrawi, E., Adcock, I. M., & Barnes, P. J. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040416 · Cited by 473
Self-citationTheophylline: New Perspectives for an Old Drug
Barnes, P. J. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200210-1142pp · Cited by 435
Self-citationAnti-inflammatory effects of low-dose oral theophylline in atopic asthma
Sullivan, P., Jaffar, Z., Page, C., Costello, J., Bekir, S., & Jeffery, P. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90127-9 · Cited by 403
Aminophylline Improves Diaphragmatic Contractility
Aubier, M., De Troyer, A., Sampson, M., Macklem, P. T., & Roussos, C. (1981) · New England Journal of Medicine · doi:10.1056/nejm198107303050503 · Cited by 399
To, Y., Ito, K., Kizawa, Y., Failla, M., Ito, M., Kusama, T., Elliott, W. M., Hogg, J. C., Adcock, I. M., & Barnes, P. J. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200906-0937oc · Cited by 352
Self-citationEvans, D. J., Taylor, D. A., Zetterstrom, O., Chung, K. F., O'Connor, B. J., & Barnes, P. J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199711133372002 · Cited by 348
Self-citationImmunomodulation by theophylline in asthma. Demonstration by withdrawal of therapy.
Kidney, J., Dominguez, M., Taylor, P. M., Rose, M., Chung, K. F., & Barnes, P. J. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.151.6.7767539 · Cited by 262
Self-citationSalmeterol Plus Theophylline Combination Therapy in the Treatment of COPD
ZuWallack, R. L., Mahler, D. A., Reilly, D., Church, N., Emmett, A., Rickard, K., & Knobil, K. (2001) · Chest · doi:10.1378/chest.119.6.1661 · Cited by 258
Murciano, D., Auclair, M.-H., Pariente, R., & Aubier, M. (1989) · New England Journal of Medicine · doi:10.1056/nejm198906083202304 · Cited by 224
Treatment Effects of Low-Dose Theophylline Combined With an Inhaled Corticosteroid in COPD
Ford, P. A., Durham, A. L., Russell, R. E. K., Gordon, F., Adcock, I. M., & Barnes, P. J. (2010) · Chest · doi:10.1378/chest.09-2363 · Cited by 190
Self-citationCulpitt, S. V., de Matos, C., Russell, R. E., Donnelly, L. E., Rogers, D. F., & Barnes, P. J. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2105106 · Cited by 181
Self-citationDose response relation to oral theophylline in severe chronic obstructive airways disease.
Chrystyn, H., Mulley, B. A., & Peake, M. D. (1988) · BMJ · doi:10.1136/bmj.297.6662.1506 · Cited by 170
Theophylline and selective PDE inhibitors as bronchodilators and smooth muscle relaxants
Rabe, K., Magnussen, H., & Dent, G. (1995) · European Respiratory Journal · doi:10.1183/09031936.95.08040637 · Cited by 170
Cosío, B. G., Iglesias, A., Rios, A., Noguera, A., Sala, E., Ito, K., Barnes, P. J., & Agustí, A. G. N. (2009) · Thorax · doi:10.1136/thx.2008.103432 · Cited by 163
Self-citationNitration of distinct tyrosine residues causes inactivation of histone deacetylase 2
Osoata, G. O., Yamamura, S., Ito, M., Vuppusetty, C., Adcock, I. M., Barnes, P. J., & Ito, K. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.04.128 · Cited by 159
Self-citationUkena, D., Harnest, U., Sakalauskas, R., Magyar, P., Vetter, N., Steffen, H., Leichtl, S., Rathgeb, F., Keller, A., & Steinijans, V. (1997) · European Respiratory Journal · doi:10.1183/09031936.97.10122754 · Cited by 159
Zhou, Y., Wang, X., Zeng, X.-Y., Qiu, R., Xie, J., Liu, S., Zheng, J., Zhong, N., & Ran, P. (2006) · Respirology · doi:10.1111/j.1440-1843.2006.00897.x · Cited by 147
Barr, R. G., Rowe, B. H., & Camargo, C. A. (2003) · BMJ · doi:10.1136/bmj.327.7416.643 · Cited by 142
Dual PDE3/4 inhibitors as therapeutic agents for chronic obstructive pulmonary disease
Banner, K. H., & Press, N. J. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00170.x · Cited by 128
Spears, M., Donnelly, I., Jolly, L., Brannigan, M., Ito, K., McSharry, C. P., Lafferty, J., Chaudhuri, R., Braganza, G., Adcock, I. M., et al. (2009) · European Respiratory Journal · doi:10.1183/09031936.00158208 · Cited by 126
Self-citationAnti-inflammatory Effects of Theophylline: Modulation of Cytokine Production
Cvietusa, P. J., Mascali, J. J., Negri, J. A., & Borish, L. (1996) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)63476-x · Cited by 125
Characterization of human cytochromes P450 involved in theophylline 8-hydroxylation
Zhang, Z., & Kaminsky, L. S. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00120-o · Cited by 124
Need for theophylline in severe steroid‐requiring asthmatics
BRENNER, M., BERKOWITZ, R., Marshall, N., & Strunk, R. C. (1988) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.1988.tb02853.x · Cited by 120
Apoptosis of eosinophils and lymphocytes in allergic inflammation
Ohta, K., & Yamashita, N. (1999) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(99)70107-7 · Cited by 110
Polosa, R., & Blackburn, M. R. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.07.005 · Cited by 108
Duffy, N., Walker, P., Diamantea, F., Calverley, P. M. A., & Davies, L. (2005) · Thorax · doi:10.1136/thx.2004.036046 · Cited by 104
Expression of Heme Oxygenase Isoenzymes 1 and 2 in Normal and Asthmatic Airways
Lim, S., Groneberg, D. A., Fischer, A., et al. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.5.9909081 · Cited by 103
Rivington, R. N., Boulet, L. P., Côté, J., Kreisman, H., Small, D. I., Alexander, M., Day, A. C., Harsanyi, Z., & Darke, A. C. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.151.2.7842186 · Cited by 94
Theophylline: Potential antiinflammatory effects in nocturnal asthma
Kraft, M., Torvik, J. A., Trudeau, J. B., Wenzel, S. E., & Martin, R. J. (1996) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(96)70191-4 · Cited by 83
PDE4: A Novel Target in the Treatment of Chronic Obstructive Pulmonary Disease
Michalski, J., Golden, G. A., Ikari, J., & Rennard, S. I. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.266 · Cited by 80
Drug interactions with azithromycin and the macrolides: an overview
Nahata, M. (1996) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/37.suppl_c.133 · Cited by 79
Dent, G., Giembycz, M. A., Rabe, K. F., Wolf, B., Barnes, P. J., & MAGNUSSEN, H. (1994) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.10.5.8179921 · Cited by 71
Self-citationKanehara, M., Yokoyama, A., Tomoda, Y., et al. (2008) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2008.09.003 · Cited by 55
Theophylline inhibits NF-κB activation and IκBα degradation in human pulmonary epithelial cells
Ichiyama, T., Hasegawa, S., Matsubara, T., Hayashi, T., & Furukawa, S. (2001) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-001-0494-x · Cited by 53
Oxidative stress modulates theophylline effects on steroid responsiveness
Marwick, J. A., Wallis, G., Meja, K. K., Küster, B., Bouwmeester, T., Chakravarty, P., Fletcher, D., Whittaker, P. A., Barnes, P. J., Ito, K., et al. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.10.065 · Cited by 52
Self-citationHirano, T., Yamagata, T., Gohda, M., Yamagata, Y., Ichikawa, T., Yanagisawa, S., Ueshima, K., Akamatsu, K., Nakanishi, M., Matsunaga, K., et al. (2006) · Thorax · doi:10.1136/thx.200x.058156 · Cited by 51
Theophylline prevents NAD+ depletion via PARP-1 inhibition in human pulmonary epithelial cells
Moonen, H. J. J., Geraets, L., Vaarhorst, A. A. M., Bast, A., Wouters, E. F. �., & Hageman, G. J. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.10.159 · Cited by 46
Aminophylline and the Respiratory Muscles: An Alternative View
Moxham, J. (1988) · Clinics in Chest Medicine · doi:10.1016/s0272-5231(21)00508-6 · Cited by 44
The Downregulation of Bcl-2 Expression Is Necessary for Theophylline-Induced Apoptosis of Eosinophil
Chung, I. Y., Namkung, E. K., Lee, N. M., Chang, H. S., Kim, D. J., Kim, Y. H., & Park, C. (2000) · Cellular Immunology · doi:10.1006/cimm.2000.1678 · Cited by 33
Voduc, N., Alvarez, G. G., Amjadi, Tessier, Sabri, S., & Aaron, S. D. (2012) · International Journal of COPD · doi:10.2147/copd.s29990 · Cited by 15
Cited by
Wearable Electrochemical Sensors for the Monitoring and Screening of Drugs
Teymourian, H., Parrilla, M., Sempionatto, J. R., Montiel, N. F., Barfidokht, A., Van Echelpoel, R., De Wael, K., & Wang, J. (2020) · ACS Sensors · doi:10.1021/acssensors.0c01318 · Cited by 423
Cardiovascular disease and COPD: dangerous liaisons?
Rabe, K. F., Hurst, J. R., & Suissa, S. (2018) · European Respiratory Review · doi:10.1183/16000617.0057-2018 · Cited by 410
The clinical toxicology of caffeine: A review and case study
Willson, C. (2018) · Toxicology Reports · doi:10.1016/j.toxrep.2018.11.002 · Cited by 289
Bin, Y., Xiao, Y., Huang, D., Ma, Z., Liang, Y., Bai, J., Zhang, W., Liang, Q., Zhang, J., Zhong, X., et al. (2019) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00005.2018 · Cited by 35
Metadata
- Authors
- Barnes, P. J.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-10-15
- Volume
- 188
- Issue
- 8
- Pages
- 901-906
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W4250109354
- Cited by
- 444
- References
- 44
- FWCI
- 14.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.